Wenjing Gao

Title: **The Innovations of Inventor Wenjing Gao**

Introduction

Wenjing Gao, a talented inventor based in Jiangsu, China, has made significant contributions in the field of biotherapeutics. With two patents to her name, she is recognized for her innovative work on chimeric antigen receptors (CAR) that are pivotal in the treatment of diseases related to BCMA expression.

Latest Patents

Wenjing Gao's most recent patents focus on a chimeric antigen receptor (CAR) designed to specifically bind to a BCMA protein. The CAR features a structural domain for BCMA binding, a transmembrane domain, a co-stimulatory domain, and an intracellular signaling domain. This invention not only enhances the binding specificity but also opens pathways for treating various diseases and conditions linked to BCMA expression.

Career Highlights

Throughout her career, Wenjing Gao has worked with prominent companies in the biotherapeutics sector. Notably, she has been associated with Nanjing Iaso Biotherapeutics Co., Ltd. and Innovent Biologics (Suzhou) Co., Ltd. Her work in these organizations has highlighted her ability to develop transformative therapies using cutting-edge technology.

Collaborations

Wenjing Gao has collaborated with esteemed colleagues, including Jianfeng Zhou and Junjian Liu. These partnerships have not only fostered the innovation of new treatment modalities but have also contributed to a collaborative research environment that enhances the quality of biotherapeutic development.

Conclusion

As an inventor, Wenjing Gao stands out for her pioneering contributions in the area of chimeric antigen receptor technology. Her patents and collaborative efforts continue to push the boundaries of biotherapeutic research and development, reflecting her commitment to enhancing patient care and treatment outcomes in diseases tied to BCMA.